PDCD1 and non-small cell lung carcinoma: Through further clinical research and long-term follow-up observations, a better understanding of the effects of different intervention strategies on sarcopenia can be gained, leading to the development of more specific nutritional treatment plans for NSCLC patients receiving PD-1 inhibitors.